DASATINIB CARBOXYLIC ACID (25 mg) ({4-[6-({5-[(2-Chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinyl}acetic acid)

In Stock
Ready to ship

Catalogue No.

1A19710

CAS No.

910297-53-9

Molecular Formula

C22H24ClN7O3S

Product Type

Pharmaceutical Analytical Impurities

$1,250.00

Quantity

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Current Lot Information

Current Lot:

F308J0

CAS RN®

910297-53-9

Harmonized System (HS) Code *:

29341000

UN No:

N/A

NDC No:

N/A

Molecular Formula

C22H24ClN7O3S

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS: Safety data sheet.pdf

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No

USP Certificates/Product Information Sheets and Valid Use Dates

Valid Use Date

Country of Origin*

Material Origin*

F308J0

1A19710-F308J0

See Product Information Sheet

India

Chemical Synthesis

Lot No

F308J0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

Catalogue No.

1A19710

CAS No.

910297-53-9

Molecular Formula

C22H24ClN7O3S

Product Type

Pharmaceutical Analytical Impurities

Catalogue No.

1A10220

CAS No.

86-48-6

Molecular Formula

C11H8O3

Product Type

Pharmaceutical Analytical Impurities

Catalogue No.

1A10000

CAS No.

27204-57-5

Molecular Formula

C13H11Cl2NO

Product Type

Pharmaceutical Analytical Impurities